Table S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Authors

Mary Kathryn Pitner (ORCID: https://orcid.org/0009-0004-7423-6072)
Chandra Bartholomeusz (ORCID: https://orcid.org/0000-0002-5806-1557)
Wendy A. Woodward (ORCID: https://orcid.org/0000-0002-7935-739X)
Geoffrey Bartholomeusz (ORCID: https://orcid.org/0000-0002-4622-4195)
Lajos Pusztai (ORCID: https://orcid.org/0000-0001-9632-6686)
Varsha Gandhi (ORCID: https://orcid.org/0000-0002-3172-9166)
Moises Tacam (ORCID: https://orcid.org/0000-0002-9292-1020)
Savitri Krishnamurthy (ORCID: https://orcid.org/0000-0001-9030-4136)
Jian Wang (ORCID: https://orcid.org/0000-0001-7104-0673)
Bisrat G. Debeb (ORCID: https://orcid.org/0000-0002-8227-2266)
Emilly S. Villodre (ORCID: https://orcid.org/0000-0002-3092-7013)
Bora Lim (ORCID: https://orcid.org/0000-0002-4182-6058)
Mohd Mughees (ORCID: https://orcid.org/0000-0002-5533-8135)
Rachel M. Layman (ORCID: https://orcid.org/0000-0002-8663-0331)
Takahiro Kogawa (ORCID: https://orcid.org/0000-0003-3730-6591)
LaKesla R. Iles (ORCID: https://orcid.org/0000-0001-6992-7910)
Naoto Tada Ueno (ORCID: https://orcid.org/0000-0002-0166-7275)
Yuan Qi (ORCID: https://orcid.org/0000-0001-9718-7593)
Xiaoding Hu (ORCID: https://orcid.org/0000-0002-3144-1859)
Debu Tripathy (ORCID: https://orcid.org/0000-0002-5711-2404)

Publication Details

Published: 2025-09-02
DOI: https://doi.org/10.1158/1535-7163.30029534
Primary Topic: Synthesis and biological activity
Type: article
Field-Weighted Citation Impact: 0.00

Table S1 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Mary Kathryn Pitner, Chandra Bartholomeusz, Wendy A. Woodward, Geoffrey Bartholomeusz, Lajos Pusztai, Varsha Gandhi, Moises Tacam, Savitri Krishnamurthy, Jian Wang, Bisrat G. Debeb, Emilly S. Villodre, Bora Lim, Mohd Mughees, Rachel M. Layman, Takahiro Kogawa, LaKesla R. Iles, Naoto Tada Ueno, Yuan Qi, Xiaoding Hu, Debu Tripathy

September 2, 2025article en

Table S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Authors

Publication Details

Table S1 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Table S1 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Table S1 from Inhibition of &lt;i&gt;MCL-1&lt;/i&gt; and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Authors

Publication Details

Table S1 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Table S1 from Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Table S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers